Mucopolysaccharidosis I under enzyme replacement therapy with laronidase--a mortality case with autopsy report.
There is little information about MPS I-related complications during laronidase therapy. We describe the first autopsy report of a young male MPS I patient who died of infection-induced cardiopulmonary failure following 2 years of weekly treatment with laronidase.